Literature DB >> 15549167

What's new in the renin-angiotensin system?

A I Smith1, A J Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15549167      PMCID： PMC7079773          DOI： 10.1007/s00018-004-4319-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


× No keyword cloud information.
  3 in total

1.  Spontaneous regression of proximal LAD subocclusive stenosis after left internal mammary artery bypass grafting.

Authors:  S Dodic; D Kovacevic; M Bjelobrk; M Petrovic; T Miljkovic; M Cankovic; B Vujin; N Cemerlic-Adjic; B Dodic
Journal:  Herz       Date:  2013-08-03       Impact factor: 1.443

2.  Patients with left main coronary artery vasospasm inadvertently undergoing coronary artery bypass grafting surgery.

Authors:  Asim A Mohammed; Andrew Yang; Kimberly Shao; Angela Disabatino; Ray Blackwell; Michael Banbury; William S Weintraub; Andrew Doorey
Journal:  J Am Coll Cardiol       Date:  2013-02-26       Impact factor: 24.094

3.  Multivessel coronary vasospasm mimicking triple-vessel obstructive coronary artery disease.

Authors:  Vineeta Ahooja; Deepak Thatai
Journal:  J Invasive Cardiol       Date:  2007-07       Impact factor: 2.022
  3 in total
  3 in total

1.  Hub Genes Identification, Small Molecule Compounds Prediction for Atrial Fibrillation and Diagnostic Model Construction Based on XGBoost Algorithm.

Authors:  Lingzhi Yang; Yunwei Chen; Wei Huang
Journal:  Front Cardiovasc Med       Date:  2022-07-14

Review 2.  The Vasoactive Mas Receptor in Essential Hypertension.

Authors:  Amalie L Povlsen; Daniela Grimm; Markus Wehland; Manfred Infanger; Marcus Krüger
Journal:  J Clin Med       Date:  2020-01-18       Impact factor: 4.241

3.  Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis.

Authors:  Meng Zhang; Wenhai Sui; Yanqiu Xing; Jing Cheng; Cheng Cheng; Fei Xue; Jie Zhang; Xiaohong Wang; Cheng Zhang; Panpan Hao; Yun Zhang
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.